Skip to main content

Peer Review reports

From: Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes

Original Submission
1 Sep 2012 Submitted Original manuscript
8 Oct 2012 Reviewed Reviewer Report - Jeffrey Evans
27 Oct 2012 Reviewed Reviewer Report - Murali Bashyam
14 Nov 2012 Author responded Author comments - George Pentheroudakis
Resubmission - Version 2
14 Nov 2012 Submitted Manuscript version 2
2 Dec 2012 Reviewed Reviewer Report - Murali Bashyam
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
30 Jan 2013 Editorially accepted
2 Feb 2013 Article published 10.1186/1471-2407-13-49

You can find further information about peer review here.

Back to article page